» Articles » PMID: 11606139

Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole Analogues As Novel Antiplatelet Agents

Overview
Journal J Med Chem
Specialty Chemistry
Date 2001 Oct 19
PMID 11606139
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

1-Benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole (28, YC-1) was selected as the lead compound for systemic structural modification. After screening for antiplatelet activity, SARs of YC-1 analogues were established. Among these potent active derivatives, compounds 29, 30, 31, 44, and 45 functioned as potent activators of sGC and inhibitors of PDE5 with potency comparable to that of YC-1. In addition, compound 58 was found to be a selective and potent inhibitor of protease-activated receptor type 4 (PAR4)-dependent platelet activation.

Citing Articles

Late-stage -C-H alkenylation of 2-arylindazoles in aqueous medium by Manganese(i)-catalysis.

Das K, Ghosh A, Hajra A RSC Adv. 2022; 12(30):19412-19416.

PMID: 35865587 PMC: 9251645. DOI: 10.1039/d2ra03547b.


Synthetic strategy and structure-activity relationship (SAR) studies of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1, Lificiguat): a review.

Yu K, Hung H RSC Adv. 2022; 12(1):251-264.

PMID: 35424505 PMC: 8978903. DOI: 10.1039/d1ra08120a.


Oxidative cross-dehydrogenative coupling (CDC) C-H bond functionalization: -butyl peroxybenzoate (TBPB)-promoted regioselective direct C-3 acylation/benzoylation of 2-indazoles with aldehydes/benzyl alcohols/styrenes.

Sharma R, Yadav L, Yadav R, Chaudhary S RSC Adv. 2022; 11(23):14178-14192.

PMID: 35423939 PMC: 8698059. DOI: 10.1039/d1ra02225c.


Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors.

Bertron J, Duvernay M, Mitchell S, Smith S, Maeng J, Blobaum A ACS Chem Neurosci. 2021; 12(24):4524-4534.

PMID: 34855359 PMC: 8823334. DOI: 10.1021/acschemneuro.1c00557.


Mn(III)-Mediated C-H Phosphorylation of Indazoles with Dialkyl Phosphites.

Ghosh P, Mondal S, Hajra A ACS Omega. 2019; 4(5):9049-9055.

PMID: 31459992 PMC: 6648136. DOI: 10.1021/acsomega.9b01121.